Biosecurity Emerging Biotechnologies and Biosecurity Risks: A New Framework for Assessing Malicious UseGlobal Biodefense StaffSeptember 11, 2025
Biosecurity The AIxBio Frontier: How U.S. Policy Could Redefine Health SecurityGlobal Biodefense StaffSeptember 2, 2025
Policy + Initiatives PAHPA at a Crossroads: How Congressional Inaction Risks America’s Health SecurityGlobal Biodefense StaffSeptember 2, 2025
Abandoning mRNA: Why HHS’ Vaccine Retreat Puts Public Health Security at Risk Health Security August 30, 2025 …
Jay Bhattacharya’s Anti-Science Turn: Undermining mRNA Vaccines and U.S. Health Security Policy + Initiatives August 18, 2025 …
Defunding Fogarty Center: A Costly Blow to Global Health and U.S. Leadership Policy + Initiatives August 17, 2025 …
Biological Weapons Convention: Sixth Session Addresses Verification and Biosecurity Policy + Initiatives August 11, 2025 …
Power Over Science: The Risks of Political Control in Federal Grantmaking Policy + Initiatives August 8, 2025 …
How mRNA Vaccine Cuts and Egg Dependency Leave the U.S. Exposed to a Bird Flu Pandemic Policy + Initiatives August 6, 2025 …
NIH Budget Cuts Threaten to Cripple U.S. Biomedical Innovation and Public Health Health Security July 28, 2025 …
UK Life Sciences Sector Plan: A Blueprint for Global Leadership and Health Security Health Security July 22, 2025 …
A Dangerous Gap: Why Phasing Out Animal Models Threatens U.S. Preparedness for CBRNE and Pandemic Threats Policy + Initiatives July 15, 2025 …
Top Medical Societies Sue Trump-Vance Administration Over Unilateral Vaccine Rollbacks Policy + Initiatives July 8, 2025 …
WHO’s Terminology Shift on Airborne Pathogens Sparks Scientific Debate Policy + Initiatives July 7, 2025 …
Biomedical Leaders Warn of ‘Catastrophic’ Fallout from Trump-Vance Research Cuts Health Security July 3, 2025 …
Gavi Summit Raises $9B for Global Vaccines as U.S. Withdraws Support Policy + Initiatives July 3, 2025 …
Hijacking Vaccine Policy: RFK Jr.’s Handpicked ACIP Undermines Science in Historic CDC Meeting Policy + Initiatives June 29, 2025 …
Politics Over Patients? FDA’s Ban on Overseas Sample Processing Undermines U.S. Biomedicine Policy + Initiatives June 25, 2025 …
Stalled Progress: AMR Advisory Council Cancellation Raises Alarm Amid Federal Inaction Antimicrobial Resistance June 25, 2025 …
